GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 281 filers reported holding GW PHARMACEUTICALS PLC in Q4 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $33,000 | +17.9% | 285 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $28,000 | -20.0% | 285 | 0.0% | 0.01% | -25.0% |
| Q2 2020 | $35,000 | +25.0% | 285 | -12.3% | 0.01% | +14.3% |
| Q1 2020 | $28,000 | -15.2% | 325 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $33,000 | -10.8% | 325 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $37,000 | -2.6% | 325 | +20.4% | 0.01% | -22.2% |
| Q2 2019 | $38,000 | -30.9% | 270 | -16.9% | 0.01% | -10.0% |
| Q1 2019 | $55,000 | +71.9% | 325 | 0.0% | 0.01% | +42.9% |
| Q4 2018 | $32,000 | -42.9% | 325 | 0.0% | 0.01% | -36.4% |
| Q3 2018 | $56,000 | +51.4% | 325 | +20.4% | 0.01% | +37.5% |
| Q2 2018 | $37,000 | +37.0% | 270 | +12.5% | 0.01% | +33.3% |
| Q1 2018 | $27,000 | +3.8% | 240 | +9.1% | 0.01% | 0.0% |
| Q4 2017 | $26,000 | – | 220 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 602,047 | $61,102,000 | 6.76% |
| FT Options LLC | 36,847 | $3,740,000 | 5.64% |
| SCOPIA CAPITAL MANAGEMENT LP | 2,988,019 | $303,254,000 | 4.80% |
| FT Options LLC | 71,000 | $1,320,000 | 1.99% |
| Rock Springs Capital Management LP | 373,000 | $37,856,000 | 1.75% |
| Redmile Group, LLC | 338,536 | $34,358,000 | 1.70% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 362,724 | $36,813,000 | 1.66% |
| Ghost Tree Capital, LLC | 50,000 | $5,075,000 | 1.08% |
| Atika Capital Management LLC | 32,500 | $3,298,000 | 0.95% |
| Sivik Global Healthcare LLC | 25,000 | $2,537,000 | 0.86% |